SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-039151
Filing Date
2015-02-09
Accepted
2015-02-09 16:09:22
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d831284d20f.htm 20-F 2660737
2 EX-2.27 d831284dex227.htm EX-2.27 473093
3 EX-8 d831284dex8.htm EX-8 6059
4 EX-10 d831284dex10.htm EX-10 2714
5 EX-12.(I) d831284dex12i.htm EX-12.(I) 6270
6 EX-12.(II) d831284dex12ii.htm EX-12.(II) 9566
7 EX-13 d831284dex13.htm EX-13 4829
14 GRAPHIC g831284ex227-seniorunsecured.jpg GRAPHIC 5986
  Complete submission text file 0001193125-15-039151.txt   18798205

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT teva-20141231.xml EX-101.INS 2946335
9 XBRL TAXONOMY EXTENSION SCHEMA teva-20141231.xsd EX-101.SCH 195483
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20141231_cal.xml EX-101.CAL 156770
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20141231_def.xml EX-101.DEF 539186
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20141231_lab.xml EX-101.LAB 1153770
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20141231_pre.xml EX-101.PRE 1050798
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-16174 | Film No.: 15588683
SIC: 2834 Pharmaceutical Preparations